BioPlus Acquisition Corp Valuation
| BIOSDelisted Stock | USD 10.73 0.00 0.00% |
At this time, the firm appears to be overvalued. BioPlus Acquisition Corp shows a prevailing Real Value of $9.06 per share. The current price of the firm is $10.73. Our model approximates the value of BioPlus Acquisition Corp from analyzing the firm fundamentals such as Return On Asset of -0.0072, shares outstanding of 19.37 M, and Shares Owned By Institutions of 51.31 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioPlus Acquisition's price fluctuation is very steady at this time. Calculation of the real value of BioPlus Acquisition Corp is based on 3 months time horizon. Increasing BioPlus Acquisition's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioPlus stock is determined by what a typical buyer is willing to pay for full or partial control of BioPlus Acquisition Corp. Since BioPlus Acquisition is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioPlus Stock. However, BioPlus Acquisition's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.73 | Real 9.06 | Hype 10.73 | Naive 10.72 |
The intrinsic value of BioPlus Acquisition's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioPlus Acquisition's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioPlus Acquisition Corp helps investors to forecast how BioPlus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioPlus Acquisition more accurately as focusing exclusively on BioPlus Acquisition's fundamentals will not take into account other important factors: BioPlus Acquisition Total Value Analysis
BioPlus Acquisition Corp is currently estimated to have valuation of 215.16 M with market capitalization of 208.98 M, debt of 5 M, and cash on hands of 294.69 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioPlus Acquisition fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
215.16 M | 208.98 M | 5 M | 294.69 K |
BioPlus Acquisition Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of BioPlus implies not a very effective usage of assets in January.BioPlus Acquisition Ownership Allocation
Over half of BioPlus Acquisition's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions.BioPlus Acquisition Profitability Analysis
Net Income was 2 M with profit before overhead, payroll, taxes, and interest of 0.About BioPlus Acquisition Valuation
The delisted stock valuation mechanism determines BioPlus Acquisition's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of BioPlus Acquisition Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioPlus Acquisition. We calculate exposure to BioPlus Acquisition's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioPlus Acquisition's related companies.BioPlus Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
BioPlus Acquisition Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioPlus Acquisition does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 597.8 M | |
| Quarterly Earnings Growth Y O Y | 58.614 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |